Biomarkers in Ankylosing Spondylitis
NCT07117344 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 160
Last updated 2026-01-20
Summary
In this study, we aimed to compare serum PGRN(progranulin) and TNF-α levels in AS patients with healthy controls and to determine the relationship between TNF-α inhibitor use and PGRN levels in AS patients.
Conditions
- Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA)
Sponsors & Collaborators
-
Bilimsel Araştirma Projeleri Birimi, Istanbul Üniversitesi
collaborator UNKNOWN -
Kirsehir Ahi Evran Universitesi
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-01-15
- Primary Completion
- 2026-07-30
- Completion
- 2026-08-30
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Biomarker Signature and Musculoskeletal Ultrasound Profile in Rheumatoid Arthritis Patients
NCT02476084 ·Status: COMPLETED
-
Survivin as Predictive Biomarker for RA
NCT03444623 ·Status: UNKNOWN
-
Etanercept (Enbrel) in Undifferentiated Spondyloarthritis
NCT01289730 ·Status: UNKNOWN ·Phase: PHASE2
-
Assessment of SpondyloArthritis Society (ASAS) Classification and Diagnostic Criteria for Early Axial Spondyloarthritis (SpA)
NCT00328068 ·Status: UNKNOWN
-
Discontinuation of TNF-alpha Inhibitors in Patients With Spondyloarthritis
NCT00726804 ·Status: TERMINATED ·Phase: PHASE4
-
Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis
NCT01934933 ·Status: COMPLETED ·Phase: PHASE4
-
Identification of New Prognostic Markers in Psoriatic Arthritis
NCT03455166 ·Status: COMPLETED ·Phase: NA
-
Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis
NCT04507763 ·Status: COMPLETED
-
Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis
NCT00432406 ·Status: COMPLETED ·Phase: PHASE4
-
Dose Reduction of Etanercept in Patients With Ankylosing Spondylitis
NCT02638896 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study To Investigate Markers Of Inflammation In Rheumatoid Arthritis
NCT00242853 ·Status: COMPLETED
-
Extension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis
NCT01118728 ·Status: TERMINATED ·Phase: PHASE2
-
Validation of a Preclinical Model Based on Patient-derived Organoids for the Study of the Gut-joint Axis in Spondyloarthritis
NCT06421116 ·Status: RECRUITING
-
Genetic Susceptibility to Ankylosing Spondylitis (AS) by Functional Genomics Approach
NCT02525042 ·Status: COMPLETED
-
Observational Study on Non-steroid Anti-inflammatory Drugs (NSAIDs) Treated Patients With Arthritic Disorder
NCT01176682 ·Status: COMPLETED
-
Serum Biomarkers Analysis in Patients With AR Treated With Anti-TMF
NCT02804204 ·Status: UNKNOWN
-
Glucocorticoid-induced Tumour Necrosis Factor Receptor Related Protein (GITR) in Rheumatoid Arthritis
NCT03763201 ·Status: UNKNOWN
-
A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole Blood
NCT00781469 ·Status: TERMINATED
-
Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes
NCT01258738 ·Status: COMPLETED ·Phase: PHASE3
-
Biomarkers in Chronic Arthritis
NCT02909998 ·Status: COMPLETED
-
A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis
NCT00134693 ·Status: COMPLETED ·Phase: PHASE2
-
Etanercept Versus Adalimumab in the Treatment of Patients With Ankylosing Spondylitis. A Switch Study
NCT02489760 ·Status: UNKNOWN ·Phase: PHASE4
-
Enhanced Clinics for Patients Diagnosed With Ankylosing Spondylitis and Psoriatic Arthritis
NCT04341233 ·Status: WITHDRAWN
-
Study During Pregnancy of Expression of miRNAs in RA or SLE
NCT02350491 ·Status: COMPLETED
-
Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
NCT00227227 ·Status: COMPLETED